Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARCUTIS BIOTHERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 237,171 shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $5.6M as of 2026-Q1. The position was increased (+2.4% shares). ARQT represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$5.6M
Current Shares
237,171
Total Value Change
+$3M
Total Shares Change
-36,608
Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC
Increased |
| 237,171 |
+2.4% |
| $5.6M |
| 0.0% |
| $23.60 |
28 |
| 2025-Q4 | Decreased | 231,734 | -5.0% | $6.7M | 0.0% | $28.08 | 0 |
| 2025-Q3 | Decreased | 244,015 | -39.7% | $4.6M | 0.0% | $18.62 | 0 |
| 2025-Q2 | Increased | 404,736 | +45.0% | $5.7M | 0.0% | $13.74 | 37 |
| 2025-Q1 | Decreased | 279,047 | -0.4% | $4.4M | 0.0% | $15.73 | 0 |
| 2024-Q4 | Increased | 280,100 | +1.2% | $3.9M | 0.0% | $14.20 | 27 |
| 2024-Q3 | Increased | 276,691 | +1.1% | $2.6M | 0.0% | $9.36 | 26 |
| 2024-Q2 | New | 273,779 | - | $2.5M | 0.0% | $9.30 | 36 |